Insights Blog
Explore our thought leadership insights, as life science technologies evolve and accelerate.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
DeciBio Q&A
Financial Services
The Early Wave of AI in Healthcare Belongs to Startups. For Now.
Healthcare went from digital laggard to one of the fastest adopters of applied AI, and we break down why the shift happened and who’s actually benefiting.
December 3, 2025
DeciBio Q&A
Financial Services
The Early Wave of AI in Healthcare Belongs to Startups. For Now.
Healthcare went from digital laggard to one of the fastest adopters of applied AI, and we break down why the shift happened and who’s actually benefiting.
December 3, 2025
AI / Machine Learning
Newsletter Update
Financial Services
Investing in Precision Medicine: VC | PE | M&A - October Round-Up 2025
October 2025 marked a period of intense deal-making across the life sciences, driven by robust financing and aggressive capital plays, primarily focusing on metabolic disease and advanced oncology.
November 19, 2025
Newsletter Update
Financial Services
Investing in Precision Medicine: VC | PE | M&A - October Round-Up 2025
October 2025 marked a period of intense deal-making across the life sciences, driven by robust financing and aggressive capital plays, primarily focusing on metabolic disease and advanced oncology.
November 19, 2025
Precision Medicine
DeciBio Ventures
Private Equity
Newsletter Update
Clinical Diagnostics
Liquid Biopsy | October Round-Up 2025
Liquid Biopsy (LBx) continued to develop through October, featuring new regulatory approvals and partnerships as well as trial launches and study results.
November 13, 2025
Newsletter Update
Clinical Diagnostics
Liquid Biopsy | October Round-Up 2025
Liquid Biopsy (LBx) continued to develop through October, featuring new regulatory approvals and partnerships as well as trial launches and study results.
November 13, 2025
Liquid Biopsy
DeciBio Q&A
Clinical Diagnostics
Current Perspective on Comprehensive Genomic Testing - Q&A with Premal Shah, Ph.D., CEO at MyOme
We recently interviewed Premal Shah, Ph.D., CEO of MyOme, a precision health company providing whole‑genome sequencing testing for proactive risk assessments, alongside clinical diagnostics offerings.
November 13, 2025
DeciBio Q&A
Clinical Diagnostics
Current Perspective on Comprehensive Genomic Testing - Q&A with Premal Shah, Ph.D., CEO at MyOme
We recently interviewed Premal Shah, Ph.D., CEO of MyOme, a precision health company providing whole‑genome sequencing testing for proactive risk assessments, alongside clinical diagnostics offerings.
November 13, 2025
Genomics Market
.png)
Newsletter Update
Clinical Diagnostics
Digital Health and Informatics | October Round-Up 2025
October 2025 brought new developments across the digital health landscape!
November 12, 2025
Newsletter Update
Clinical Diagnostics
Digital Health and Informatics | October Round-Up 2025
October 2025 brought new developments across the digital health landscape!
November 12, 2025
Digital Health
Health Technology Market
Women's Health
Medical Devices
DeciBio News
Clinical Diagnostics
Worldwide In Vitro Diagnostics (IVD) market forecasted to grow at 4% p.a., reaching $109B by 2030 – Market Report by DeciBio Consulting LLC
This report covers IVD testing spanning across diagnostic modalities and therapeutic areas, providing a detailed assessment of each segment of the market.
November 11, 2025
DeciBio News
Clinical Diagnostics
Worldwide In Vitro Diagnostics (IVD) market forecasted to grow at 4% p.a., reaching $109B by 2030 – Market Report by DeciBio Consulting LLC
This report covers IVD testing spanning across diagnostic modalities and therapeutic areas, providing a detailed assessment of each segment of the market.
November 11, 2025
DeciBio News
Diagnostics Market
Precision Medicine is evolving at a rapid pace
Discover how we can help
Get in Touch
© DeciBio 2023 | All rights reserved